• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Analysis: As Biosimilar Of Key Cancer Drug Spreads, Where Is The Price Reduction?

11/12/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Asia/Pacific, Development, English, Finance, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

Special Report: A Look Behind Hepatitis C Patent Challenges Worldwide

15/11/2017 by Tatum Anderson for Intellectual Property Watch 2 Comments

A case at the High Court in India set for 15 December could decide whether a patent on some of the most important drugs to fight hepatitis C should be removed. It is one of many attempts to challenge patents on hepatitis C drugs in various countries around the world and serves as an opportunity to learn more about the group leading the legal case.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Human Rights, IP Law, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

Hepatitis C Buyers’ Clubs Grow Worldwide As A Way To Obtain Affordable Treatment

07/11/2017 by Tatum Anderson for Intellectual Property Watch Leave a Comment

Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million worldwide and kills around 400,000 people a year. But importantly, these groups of patients from Russia to Australia have got together to help each other import a relatively new class of drug that is able to cure most of the patients who take it.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Europe, Finance, Health & IP, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Regional Policy, WHO

Access To Generic Reproductive Health Supplies Decades Behind Medicines?

19/09/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA]

Filed Under: IP Policies, Language, Themes, Venues, Enforcement, English, Health & IP, Health Policy Watch, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, United Nations - other

Better Data On Fake Drugs Needed To Fight The Scourge

30/08/2017 by Tatum Anderson for Intellectual Property Watch Leave a Comment

The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Europe, Health Policy Watch, Human Rights, Patents/Designs/Trade Secrets, Regional Policy, WHO

Enter The African Medicines Agency, Continent’s First Super-Regulator?

03/07/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Africa, Development, English, Featured, Finance, Health Policy Watch, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

Polypills: Are Miracle Treatments Being Overlooked?

05/06/2017 by Tatum Anderson for Intellectual Property Watch Leave a Comment

Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Health Policy Watch, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, WHO

Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars?

10/05/2017 by Tatum Anderson for Intellectual Property Watch 2 Comments

The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars.

Filed Under: IP Policies, Language, Themes, English, Health & IP, Health Policy Watch, Patents/Designs/Trade Secrets

The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP

12/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to prescribe antibiotics in the first place.

Filed Under: IP Policies, Subscribers, Themes, Venues, English, Europe, Finance, Health & IP, Innovation/ R&D, Other International Orgs, Patents/Designs/Trade Secrets, Regional Policy

Public-Private Coalition’s High-Profile Delinkage Policy For Emerging Vaccines

04/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

It’s early February in Tchaourou district, Borgou in Benin, and a pregnant woman is admitted to hospital. Her premature baby is born by caesarean section but she dies a day later on February 12th. It turns out she had Lassa fever, a deadly viral haemorrhagic disease. But that’s only discovered after the baby is discharged from hospital and taken to northern Togo. The newborn also becomes ill and is taken to hospital for treatment.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Africa, Development, English, Finance, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting